{"id":58958,"date":"2026-02-23T07:08:29","date_gmt":"2026-02-23T11:08:29","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/novo-nordisk-signals-further-weight-loss-potential-as-eu-freezes-us-trade-deal\/58958\/"},"modified":"2026-02-23T07:08:29","modified_gmt":"2026-02-23T11:08:29","slug":"novo-nordisk-signals-further-weight-loss-potential-as-eu-freezes-us-trade-deal","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/novo-nordisk-signals-further-weight-loss-potential-as-eu-freezes-us-trade-deal\/58958\/","title":{"rendered":"Novo Nordisk Signals Further Weight Loss Potential as EU Freezes US Trade Deal"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>Novo Nordisk (<a href=\"\/stock\/NVO\">NVO<\/a>) CSO Martin Holst Lange<\/strong> believes the company&#39;s next-generation drug, <strong>CagriSema<\/strong>, has untapped weight loss potential beyond the <strong>23% reduction<\/strong> observed in recent Phase III trials.<\/li>\n<li><strong>The European Union<\/strong> has moved to freeze the ratification of the <strong>&quot;Turnberry Agreement&quot;<\/strong> with the United States, citing &quot;customs chaos&quot; and legal uncertainty following new <strong>15% global tariffs<\/strong> from the <a href=\"https:\/\/thestockmarketwatch.com\/live\/trump-stock-market\" data-internallinksmanager029f6b8e52c=\"8\" title=\"Trump\">Trump<\/a> administration.<\/li>\n<li><strong>The European Commission<\/strong> raised approximately <strong>\u20ac6.09 billion<\/strong> through a triple-tranche bond auction, with yields for 2030 and 2038 maturities falling significantly compared to previous sales.<\/li>\n<li><strong>Russia&#39;s Rosatom<\/strong> has formally offered to build a nuclear power plant in <strong>Serbia<\/strong>, intensifying a geopolitical bidding war as the Balkan nation also considers a partnership with France\u2019s EDF.<\/li>\n<\/ul>\n<h2>Novo Nordisk Eyes Superior Efficacy for CagriSema<\/h2>\n<p>Novo Nordisk (<a href=\"\/stock\/NVO\">NVO<\/a>) Chief Scientific Officer Martin Holst Lange stated on Monday that the company assumes there is <strong>further weight loss potential<\/strong> to be unlocked with <strong>CagriSema<\/strong>. This optimism follows headline results from the <strong>REDEFINE 4<\/strong> trial, where the drug\u2014a combination of semaglutide and cagrilintide\u2014achieved a <strong>23% weight loss<\/strong> over 84 weeks.<\/p>\n<p>The company is currently exploring <strong>higher-dose combinations<\/strong> and longer trial durations to determine the drug&#39;s ultimate efficacy ceiling. CagriSema is positioned as a critical successor to <strong>Wegovy<\/strong>, aimed at defending market share against Eli Lilly (<a href=\"\/stock\/LLY\">LLY<\/a>), whose competing treatment <strong>Zepbound<\/strong> has shown high efficacy in similar patient populations.<\/p>\n<h2>EU Halts US Trade Deal Amid Tariff Volatility<\/h2>\n<p>The European Parliament\u2019s trade chief, <strong>Bernd Lange<\/strong>, proposed an immediate freeze on the approval process for the <strong>Turnberry Agreement<\/strong>, a major trade deal intended to stabilize transatlantic relations. The move comes in response to <strong>President Donald <a href=\"https:\/\/thestockmarketwatch.com\/live\/trump-stock-market\" data-internallinksmanager029f6b8e52c=\"8\" title=\"Trump\">Trump<\/a>\u2019s<\/strong> decision to hike global tariffs to <strong>15%<\/strong> and a subsequent U.S. Supreme Court ruling that struck down certain emergency tariff powers.<\/p>\n<p>Lange characterized the current situation as <strong>&quot;pure customs chaos,&quot;<\/strong> noting that the legal basis for the agreement has shifted fundamentally. The EU is demanding a <strong>comprehensive legal assessment<\/strong> and clear commitments from Washington before proceeding with any legislative work on the deal, which was originally slated for ratification by March.<\/p>\n<h2>Mixed Yields in Major EU Bond Auctions<\/h2>\n<p>The European Union successfully auctioned three separate bond tranches on Monday, totaling over <strong>\u20ac6 billion<\/strong> in issuance. The <strong>\u20ac2.176 billion<\/strong> sale of 2030 bonds saw the average yield drop to <strong>2.454%<\/strong>, down from <strong>2.805%<\/strong> in the previous auction, reflecting strong investor appetite despite broader market volatility.<\/p>\n<p>In contrast, the <strong>\u20ac1.986 billion<\/strong> auction of 2028 bonds saw a slight yield increase to <strong>2.185%<\/strong> from a previous <strong>2.128%<\/strong>. The longest maturity offered, a <strong>\u20ac1.93 billion<\/strong> tranche of 2038 bonds, cleared at an average yield of <strong>3.319%<\/strong>, significantly lower than the <strong>3.489%<\/strong> recorded in the prior sale, with a bid-to-cover ratio of <strong>1.16x<\/strong>.<\/p>\n<h2>Rosatom Challenges Western Influence in Serbian Energy<\/h2>\n<p>Alexey Likhachev, head of the Russian state nuclear corporation <strong>Rosatom<\/strong>, announced that Russia is ready to provide <strong>Serbia<\/strong> with a nuclear power plant project based on Russian technology. The offer includes the possibility of forming an <strong>international consortium<\/strong> to manage the project, providing Serbia with flexibility in how it develops its first nuclear facility.<\/p>\n<p>The proposal follows Serbia&#39;s recent decision to lift a <strong>35-year moratorium<\/strong> on nuclear energy to meet growing demand driven by AI development and decarbonization goals. While Rosatom is a global leader with <strong>30 projects<\/strong> currently under construction, Serbia is also in active negotiations with the French energy giant <strong>EDF<\/strong>, signaling a strategic competition between Eastern and Western technology providers.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Novo Nordisk (NVO) CSO Martin Holst Lange believes the company&#39;s next-generation drug, CagriSema, has untapped weight loss potential [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[5024,5030,5039,5124,5227,6773,7470,17569],"class_list":["post-58958","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-trade","tag-energy","tag-eu","tag-bonds","tag-healthcare","tag-lly-stock-lly","tag-nvo-stock-nvo","tag-rosatom"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/58958","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=58958"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/58958\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=58958"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=58958"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=58958"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}